Literature DB >> 31106425

Epithelial-mesenchymal transition in the formation of hypertrophic scars and keloids.

Feng-Lai Yuan1, Zi-Li Sun2, Yi Feng3, Si-Yu Liu1, Yong Du1, Shun Yu1, Ming-Lie Yang1, Guo-Zhong Lv1.   

Abstract

Abnormal wound healing is likely to induce the formation of hypertrophic scars and keloids, which leads to dysfunction, deformity, and mental problem in the patients. Despite the advances in prevention and management of hypertrophic scar and keloids, the mechanism underlying scar and keloid formation has not been fully elucidated. Recent insights into the role of the epithelial-mesenchymal transition (EMT) in development, wound healing, stem cell regulation, fibrosis, and tumorigenesis have increased our understanding of the pathophysiology of hypertrophic scarring and keloids and suggested new therapeutic targets. This review summarizes recent progress in the elucidation of the role of EMT in physiologic wound healing and pathologic scar formation. This knowledge will facilitate an understanding of EMT roles in scar formation and shed new light on the modulation and potential treatment of hypertrophic scars and keloids.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  epithelial-mesenchymal transition; extracellular matrix; hypertrophic scar; keloid; wound healing

Mesh:

Year:  2019        PMID: 31106425     DOI: 10.1002/jcp.28830

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  8 in total

1.  Comparative Efficacy and Safety of Common Therapies in Keloids and Hypertrophic Scars: A Systematic Review and Meta-analysis.

Authors:  Xia Li; Feng-Lai Yuan
Journal:  Aesthetic Plast Surg       Date:  2019-12-09       Impact factor: 2.326

2.  Targeted apoptosis of myofibroblasts by elesclomol inhibits hypertrophic scar formation.

Authors:  Yi Feng; Jun-Jie Wu; Zi-Li Sun; Si-Yu Liu; Ming-Li Zou; Zheng-Dong Yuan; Shun Yu; Guo-Zhong Lv; Feng-Lai Yuan
Journal:  EBioMedicine       Date:  2020-04-03       Impact factor: 8.143

3.  Detection and analysis of long noncoding RNA expression profiles related to epithelial-mesenchymal transition in keloids.

Authors:  Zhixiong Chen; Xi Chu; Jinghong Xu
Journal:  Biomed Eng Online       Date:  2022-01-11       Impact factor: 2.819

4.  Eupalinilide B as a novel anti-cancer agent that inhibits proliferation and epithelial-mesenchymal transition in laryngeal cancer cells.

Authors:  Linlin Jiang; Lei Zhang; Xinran Zhang
Journal:  J Int Med Res       Date:  2022-01       Impact factor: 1.671

5.  Comprehensive Analysis of Circular RNA Expression in ceRNA Networks and Identification of the Effects of hsa_circ_0006867 in Keloid Dermal Fibroblasts.

Authors:  Qianqian Pang; Xiaohu Lin; Jiaqi Sun; Jie Hu; Siya Dai; Yichen Shen; Mingyuan Xu; Jinghong Xu
Journal:  Front Mol Biosci       Date:  2022-01-31

Review 6.  Application of ADSCs and their Exosomes in Scar Prevention.

Authors:  Cong Li; Shuqiang Wei; Quanchen Xu; Yu Sun; Xuchao Ning; Zhiguo Wang
Journal:  Stem Cell Rev Rep       Date:  2021-09-12       Impact factor: 5.739

7.  WNT5A drives interleukin-6-dependent epithelial-mesenchymal transition via the JAK/STAT pathway in keloid pathogenesis.

Authors:  Young In Lee; Jung Eun Shim; Jihee Kim; Won Jai Lee; Jae Woo Kim; Kee Hyun Nam; Ju Hee Lee
Journal:  Burns Trauma       Date:  2022-10-07

Review 8.  Epithelial-Mesenchymal Transition (EMT): The Type-2 EMT in Wound Healing, Tissue Regeneration and Organ Fibrosis.

Authors:  Guya D Marconi; Luigia Fonticoli; Thangavelu Soundara Rajan; Sante D Pierdomenico; Oriana Trubiani; Jacopo Pizzicannella; Francesca Diomede
Journal:  Cells       Date:  2021-06-23       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.